Connection

William Creasman to Endometrial Neoplasms

Back to Details
This is a "connection" page, showing publications William Creasman has written about Endometrial Neoplasms.
William Creasman
Connection Strength
4.735
Endometrial Neoplasms
  1. Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol. Gynecol Oncol. 2017 06; 145(3):519-525.
    View in: PubMed
    Score: 0.547
  2. The current status of lymphadenectomy in the management of endometrial cancer. Womens Health (Lond). 2011 Jan; 7(1):33-5.
    View in: PubMed
    Score: 0.355
  3. ASTEC lymphadenectomy and radiation therapy studies: are conclusions valid? Gynecol Oncol. 2010 Mar; 116(3):293-4.
    View in: PubMed
    Score: 0.327
  4. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet. 2009 May; 105(2):109.
    View in: PubMed
    Score: 0.314
  5. Controversies surrounding lymphadenectomy and postoperative radiotherapy in the treatment of carcinoma of the endometrium. Future Oncol. 2008 Jun; 4(3):379-87.
    View in: PubMed
    Score: 0.296
  6. Hormone replacement therapy after cancers. Curr Opin Oncol. 2005 Sep; 17(5):493-9.
    View in: PubMed
    Score: 0.245
  7. Prognosis of papillary serous, clear cell, and grade 3 stage I carcinoma of the endometrium. Gynecol Oncol. 2004 Dec; 95(3):593-6.
    View in: PubMed
    Score: 0.233
  8. Expression of cyclooxygenase-2 in cervical, endometrial, and ovarian malignancies. Am J Obstet Gynecol. 2003 May; 188(5):1174-6.
    View in: PubMed
    Score: 0.208
  9. Estrogen and cancer. Gynecol Oncol. 2002 Jul; 86(1):1-9.
    View in: PubMed
    Score: 0.197
  10. Significance of true surgical pathologic staging: a Gynecologic Oncology Group Study. Am J Obstet Gynecol. 1999 Jul; 181(1):31-4.
    View in: PubMed
    Score: 0.160
  11. HRT and women who have had breast or endometrial cancer. J Epidemiol Biostat. 1999; 4(3):217-20; discussion 221-5.
    View in: PubMed
    Score: 0.154
  12. Receipt of adjuvant endometrial cancer treatment according to race: an?NRG Oncology/Gynecologic Oncology Group 210 Study. Am J Obstet Gynecol. 2018 11; 219(5):459.e1-459.e11.
    View in: PubMed
    Score: 0.150
  13. An NRG Oncology/GOG study of molecular classification for risk prediction in endometrioid endometrial cancer. Gynecol Oncol. 2018 01; 148(1):174-180.
    View in: PubMed
    Score: 0.143
  14. Endometrial carcinoma recurrence according to race and ethnicity: An NRG Oncology/Gynecologic Oncology Group 210 Study. Int J Cancer. 2018 03 15; 142(6):1102-1115.
    View in: PubMed
    Score: 0.142
  15. Dysregulation of miR-181c expression influences recurrence of endometrial endometrioid adenocarcinoma by modulating NOTCH2 expression: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2017 12; 147(3):648-653.
    View in: PubMed
    Score: 0.141
  16. Nonsteroidal Anti-inflammatory Drugs and Endometrial Carcinoma Mortality and Recurrence. J Natl Cancer Inst. 2017 03 01; 109(3):1-10.
    View in: PubMed
    Score: 0.136
  17. Endometrial cancer: incidence, prognostic factors, diagnosis, and treatment. Semin Oncol. 1997 Feb; 24(1 Suppl 1):S1-140-S1-50.
    View in: PubMed
    Score: 0.135
  18. The role of racial genetic admixture with endometrial cancer outcomes: An NRG Oncology/Gynecologic Oncology Group study. Gynecol Oncol. 2016 Feb; 140(2):264-9.
    View in: PubMed
    Score: 0.124
  19. Associations between etiologic factors and mortality after endometrial cancer diagnosis: the NRG Oncology/Gynecologic Oncology Group 210 trial. Gynecol Oncol. 2015 Oct; 139(1):70-6.
    View in: PubMed
    Score: 0.122
  20. Relationships of Tubal Ligation to Endometrial Carcinoma Stage and Mortality in the NRG Oncology/ Gynecologic Oncology Group 210 Trial. J Natl Cancer Inst. 2015 Sep; 107(9).
    View in: PubMed
    Score: 0.121
  21. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol. 2013 May; 129(2):277-84.
    View in: PubMed
    Score: 0.103
  22. Prognostic significance of hormone receptors in endometrial cancer. Cancer. 1993 Feb 15; 71(4 Suppl):1467-70.
    View in: PubMed
    Score: 0.103
  23. Adenocarcinoma of the uterine corpus. Curr Opin Obstet Gynecol. 1993 Feb; 5(1):80-3.
    View in: PubMed
    Score: 0.102
  24. Recommendations regarding estrogen replacement therapy after treatment of endometrial cancer. Oncology (Williston Park). 1992 Jul; 6(7):23-6; discussion 26, 28.
    View in: PubMed
    Score: 0.098
  25. Clinical evaluation of atypical glandular cells of undetermined significance. Am J Obstet Gynecol. 2001 Jan; 184(2):64-9.
    View in: PubMed
    Score: 0.044
  26. A phase II trial of prolonged oral etoposide (VP-16) as second-line therapy for advanced and recurrent endometrial carcinoma: a Gynecologic Oncology Group study. Gynecol Oncol. 1996 Oct; 63(1):101-4.
    View in: PubMed
    Score: 0.033
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.